98 related articles for article (PubMed ID: 6280337)
1. HLA antigens in patients with recrudescent herpes simplex infections.
Legendre C; Russell AS; Jeannet M
Tissue Antigens; 1982 Jan; 19(1):85-9. PubMed ID: 6280337
[TBL] [Abstract][Full Text] [Related]
2. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
Cunningham AL; Noble JR
J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
[TBL] [Abstract][Full Text] [Related]
3. HLA-D typing with an association of Dw2 and absent immune responses towards herpes simplex (type i) antigen in multiple sclerosis.
Paty DW; Cousin HK; Stiller CR; Boucher DW; Furesz J; Warren KG; Marchuk L; Dossetor JB
Transplant Proc; 1977 Dec; 9(4):1845-8. PubMed ID: 203060
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex antigen in immune complexes of patients with erythema multiforme: presence following recurrent herpes simplex infection.
Kazmierowski JA; Peizner DS; Wuepper KD
JAMA; 1982 May; 247(18):2547-50. PubMed ID: 6279897
[TBL] [Abstract][Full Text] [Related]
5. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
6. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
Zaia JA; Palmer EL; Feorino PM
J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
[TBL] [Abstract][Full Text] [Related]
7. [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].
Wassilew SW; Koch I
Arch Dermatol Res; 1978 Aug; 262(3):267-74. PubMed ID: 214045
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation in patients with recrudescent orofacial herpes simplex virus infections.
Vestey JP; Norval M; Howie SE; Maingay JP; Neill W
Br J Dermatol; 1990 Jan; 122(1):33-42. PubMed ID: 2153401
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations.
Ljungman P; Zetterqvist L; Sundqvist VA; Jeansson S; Heimdahl A; Wahren B
Clin Exp Immunol; 1988 May; 72(2):207-10. PubMed ID: 2842095
[TBL] [Abstract][Full Text] [Related]
10. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes.
Torpey DJ; Lindsley MD; Rinaldo CR
J Immunol; 1989 Feb; 142(4):1325-32. PubMed ID: 2464644
[TBL] [Abstract][Full Text] [Related]
11. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection.
Burchett SK; Corey L; Mohan KM; Westall J; Ashley R; Wilson CB
J Infect Dis; 1992 May; 165(5):813-8. PubMed ID: 1314868
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
O'Reilly RJ; Chibbaro A; Anger E; Lopez C
J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
[TBL] [Abstract][Full Text] [Related]
13. Association of Herpes simplex virus (HSV) with cervical cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens.
Smith JW; Torres JE; Holmquist ND
Am J Epidemiol; 1979 Aug; 110(2):141-7. PubMed ID: 223438
[TBL] [Abstract][Full Text] [Related]
14. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
15. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.
Donnenberg AD; Bell RB; Aurelian L
Cell Immunol; 1980 Dec; 56(2):526-39. PubMed ID: 6258811
[No Abstract] [Full Text] [Related]
16. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
Vestey JP; Norval M; Howie S; Maingay J; Neill WA
Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
[TBL] [Abstract][Full Text] [Related]
17. Human T cell response to Herpes simplex virus antigen in vitro.
Berle EJ; Thorsby E
Acta Pathol Microbiol Scand C; 1980 Feb; 88(1):31-7. PubMed ID: 6246714
[TBL] [Abstract][Full Text] [Related]
18. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
[TBL] [Abstract][Full Text] [Related]
19. Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infections.
Seppänen M; Lokki ML; Timonen T; Lappalainen M; Jarva H; Järvinen A; Sarna S; Valtonen V; Meri S
Clin Infect Dis; 2001 Nov; 33(9):1604-7. PubMed ID: 11577377
[TBL] [Abstract][Full Text] [Related]
20. [Relations of HLA A2, A3, B12 antigens, and A2-B12 supposed haplotype association, with latent herpes virus infection in patients with chronic renal disease (author's transl)].
Ruffault A; Fauconnier B; Fauchet R; Genetet B
Pathol Biol (Paris); 1979 May; 27(5):293-6. PubMed ID: 228227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
